GlassScriptPhysician profile
Marty L Prah
NPI 1528065125
$9,787.05
in general payments reported to CMS, 2019-2025
55 companies · $806 in 2025
The $806 reported for 2025 was more than what a typical Urology provider received nationally (typical 2025 total: $631).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,567 · 2020: $563 · 2021: $633 · 2022: $1,841 · 2023: $1,928 · 2024: $1,448 · 2025: $806.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,742 · Travel and Lodging: $341 · Education: $99.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,741.93 |
| Travel and Lodging | $340.87 |
| Education | $99.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Teleflex LLC | $1,886.99 | 2022-2025 | Urolift, Barrigel |
| Neotract INC. | $1,785.43 | 2019-2020 | |
| Astellas Pharma US INC | $1,459.81 | 2019-2025 | Xtandi, Myrbetriq, Veozah |
| Sumitomo Pharma America, INC. | $558.71 | 2023-2025 | Gemtesa, Orgovyx |
| Abbvie INC. | $384.05 | 2019-2025 | |
| Procept Biorobotics Corporation | $326.78 | 2022-2025 | Aquabeam Robotic System, Aquabeam System |
| Dornier Medtech America, INC | $310.45 | 2019-2023 | Dornier Medtech |
| Janssen Biotech, INC. | $302.96 | 2019-2025 | Erleada |
| Boston Scientific Corporation | $215.24 | 2020-2025 | Upsylon, Spaceoar Vue System - 10ml, General - Erectile Dysfunction |
| Pfizer INC. | $197.71 | 2019-2024 | |
| Urogen Pharma, INC. | $196.34 | 2021-2025 | Jelmyto |
| Coloplast Corp | $151.13 | 2019-2025 | |
| Endo Pharmaceuticals INC. | $139.39 | 2019-2023 | Xiaflex, Aveed |
| Ambu INC. | $120.14 | 2021-2024 | |
| Verity Pharmaceuticals INC. | $115.47 | 2022-2025 | Trelstar, Tlando |
Show all 55 companies
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Marty Prah listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.